ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

Mankind Pharma Limited Complete list of announcements declared & dividend announcements by Mankind Pharma Limited MANKIND

Mankind Pharma Limited MANKIND listed on NSE and deals in

Announcements and dividends declared by Mankind Pharma Limited MANKIND

Mankind Pharma partners with Innovent to aid cancer treatment in India
Mankind Pharma has partnered with Innovent Biologics to bring sintilimab, a PD-1 immunotherapy, to India. The drug treats various cancers and improves patient access to innovative therapies. Mankind Pharma will manage registration, import, marketing, and d
Announcement as on 26 December 2024

Mankind Pharma inks licensing pact with Innovent to commercialise Sintilimab in India
Mankind Pharma Ltd and Innovent Biologics have partnered to license and commercialise the cancer immunotherapy drug Sintilimab in India. They aim to enhance cancer treatment and patient access to innovative therapies. Mankind Pharma plans to seek regulator
Announcement as on 26 December 2024

Company Announcement
Mankind Pharma Limited has informed the Exchange regarding allotment of 11904761 securities pursuant to Qualified Institution Placement at its meeting held on December 20, 2024
Announcement as on 20 December 2024

Adani Total Gas and Mankind Pharma among 11 stocks that may lose their largecap status
The Association of Mutual Funds in India (AMFI) will announce the stock re-categorization in the first week of January 2025
Announcement as on 18 December 2024

Company Announcement
Mankind Pharma Limited has informed the Exchange about qualified Institutional Placement
Announcement as on 18 December 2024

Announcements by Mankind Pharma Limited first page | Next page | Prev page |

MANKIND Mankind Pharma Limited current price & indicator signals

Moving Averages for Mankind Pharma Limited

  • 5Day Average: 2196.64
  • 12Day Average: 2114.66
  • 20Day Average: 2104.47
  • 50Day Average: 2144.37
  • 100Day Average: 2221.7
  • 150Day Average: 2326.8
  • 200Day Average: 2357.09

MANKIND Indicators & signals

Indicator MACD (12,26,9)

2147.68, 2128.6, -7.7
Indicator MACD is in positive zone

Indicator ADX (14)

14.62, 29.23, 21.78
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 61
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MANKIND Mankind Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Mon Mar 2026 2245.50 2161.00 to 2251.10 -0.09% 0.85 times
27 Fri Feb 2026 2247.60 2235.00 to 2275.00 -1.41% 1.23 times
26 Thu Feb 2026 2279.70 2145.90 to 2284.90 5.75% 4.3 times
25 Wed Feb 2026 2155.70 2052.80 to 2165.00 4.92% 1.25 times
24 Tue Feb 2026 2054.70 2029.40 to 2060.60 0.4% 0.34 times
23 Mon Feb 2026 2046.60 2012.30 to 2050.00 1.1% 0.34 times
20 Fri Feb 2026 2024.30 2014.90 to 2057.30 -0.75% 0.32 times
19 Thu Feb 2026 2039.50 2031.00 to 2088.40 -1.74% 1.15 times
18 Wed Feb 2026 2075.60 2048.00 to 2078.30 0.62% 0.33 times
17 Tue Feb 2026 2062.90 2060.00 to 2088.30 -0.98% 0.4 times
16 Mon Feb 2026 2083.30 2051.70 to 2085.50 1.11% 0.34 times
13 Fri Feb 2026 2060.50 2050.10 to 2085.30 -0.89% 0.32 times

Videos related to: MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

 

Back to top